Michael T Hemann

21PUBLICATIONS
147CO-AUTHORS
Molecular targetsBiomolecular modelling and designCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 08, 2026
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

|Nov 24, 2025
A functional map of CDK-drug interactions at single amino acid resolution.

Samuel I Gould, Jonuelle Acosta, Luca Boscolo Bielo

|Oct 20, 2025
Leveraging platinum-protein interactions to overcome chemoresistance.

Fang Wang, Jonathan Braverman, George Eng

|Sep 10, 2025
Sensitization of cancer cells to DNA-damaging agents by expression of the REV1 C-terminal domain: Implications for chemotherapy.

Ke Bian, Charley C Gruber, Emine Byers

|Mar 10, 2025
Multiplexed in vivo base editing identifies functional gene-variant-context interactions.

Jonuelle Acosta, Grace A Johnson, Samuel I Gould

|Dec 20, 2024
FAS-less allogeneic CAR T cells.

Keith P Eidell, Michael T Hemann

Pageof 4

Frequent Collaborators

4 joint publications

Graham C Walker

3 joint publications

Gabriela Alexe

3 joint publications

Lina Benajiba

3 joint publications

Francisco J Sánchez-Rivera